Recruiting

Behavioral Strategies

Sponsor:

Bradley Hospital

Code:

NCT04035057

Conditions

Anxiety Disorders

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Accepted

Interventions

Behaviorally Enhanced Training

Standard Didactic Training

Study Details

Brief summary:

The goal of this study is to test a targeted training for overcoming known barriers to the uptake and quality delivery of exposure therapy among community mental health providers. The first phase (Year 1) of the study is a case-series analysis of six therapists with the goal of determining whether the targeted training strategies (i.e., exposure to exposure) are capable of engaging therapists' reservations about exposure. Information from the first phase will be used to optimize the behavioral training strategies to be tested in the second phase. The second phase (Years 2 \& 3) will be a randomized trial of training conditions comparing Behaviorally Enhanced Training Strategies to a Standard Didactic Training. After an initial workshop training, therapists in the second phase will receive ongoing consultation while they deliver exposure therapy with their anxious patients. Sessions will be video-recorded and therapist behaviors will be coded to assess for differences in the manner in which exposure is delivered between training conditions.

Conditions

Anxiety Disorders

Study ID

NCT04035057

Start date

Mar 1, 2019

Status verified date

Jul, 2019

Completion date

Dec 31, 2021

Anticipated

Primary completion date

Dec 31, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Accepted

Inclusion Criteria: Therapists

  • Agency hours >8 hours a week.

Exclusion Criteria:

  • Training procedure are unacceptable to therapist

Patient Participants: Age 5 - 17 years

Inclusion Criteria:

  • Primary or co-primary diagnosis of Separation Anxiety Disorder, Specific Phobia, Social Anxiety Disorder, Panic Disorder, or OCD
  • Children < age 12 have a caretaker available to participate in treatment
  • Patient and at least one parent are English speaking

Exclusion Criteria:

  • Concurrent psychotherapy for treatment of anxiety
  • Psychosis, Pervasive Developmental Disorder, or Mental Retardation.

Study Design

Enrollment

32 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Behaviorally Enhanced Training Strategies

Both training conditions will receive a 1.5 day training followed by ongoing supervision while they implement exposure therapy with patients recruited to the study. The first full day will consist of the same foundational information in both conditions. The two conditions will differ in their training focus during the subsequent half-day training. The Behaviorally Enhanced condition will involve therapist engagement in repeated self-exposure and partner-exposure exercises with the goal of targeting and reducing therapists' reservations about using exposure with their patients. The focus of ongoing supervision following the initial 1.5 day training workshop will also differ by condition. The Behaviorally Enhanced condition will include regular sampling and feedback on therapists' remaining reservations about exposure in additional to counseling the implementation of exposure with therapists' patients.

active comparator: Standard Didactic Training

Both training conditions will receive a 1.5 day training followed by ongoing supervision while they implement exposure therapy with patients recruited to the study. The first full day will consist of the same foundational information in both conditions.The two conditions will differ in their training focus during the subsequent half-day training. The Standard Didactic condition will involve additional didactic instruction related to common barriers and more advanced delivery concepts than will be presented in the half-day training for the Behaviorally Enhanced condition. The focus of ongoing supervision following the initial 1.5 day training workshop will also differ by condition. The Standard Didactic condition will involve counseling on the implementation of exposure with therapists' patients without explicit focus on therapists' remaining reservations about exposure.

Interventions

Behaviorally Enhanced Training

Therapists in the Behaviorally Enhanced Training will receive the same didactic instruction as those in the Standard Didactic Training arm during the first full day of training. In the second half-day training, those in the Behaviorally Enhanced Training arm will focus on behavioral strategies (i.e., exposure to exposure) that provide direct experience with the process of treatment delivery.

Standard Didactic Training

Therapists in the Standard Didactic Training arm will complete training as usual, consisting of PowerPoint and video training tasks instructing the delivery of exposure therapy for anxious youth.

Primary outcome measure

  • Change in therapist reservations about exposure [ Time Frame: Baseline (pre-workshop) & End of the 1.5 day Training Workshop ]
  • Change in therapist reservations about exposure [ Time Frame: End of 1.5 day Training Workshop & End of Therapist Participation in the Study, on average 1 year. ]
  • Therapist Delivery Behavior [ Time Frame: The first 12 exposure sessions with patients recruited to the study will be videotaped and coded, on average 3 months. ]

Central Contacts and Locations

Central contacts

Joshua Kemp, PhD

401-432-1466joshua.kemp@lifespan.org

Lauren Edwards, B.S.

401-432-1468ledwards@lifespan.org

Locations

Bradley Hospital

Recruiting

Riverside, Rhode Island, United States, 02915

Contacts

Joshua Kemp, PhD

401-432-1466joshua.kemp@lifespan.org

Principal Investigator:

Joshua Kemp, PhD

More Information

Sponsor

Bradley Hospital

Last update posted

Jul 29, 2019

Last verified

Jul, 2019

Keywords

  • Therapist Training
  • Exposure Therapy
  • Experimental Therapeutics

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Bradley Hospital on 2019-07-29.